Previous 10 | Next 10 |
2023-11-03 07:44:52 ET Novavax (NASDAQ: NVAX) stock price has been a huge disappointment among investors in the past few months. After peaking at $332 during the Covid-19 pandemic, the shares have tumbled to $7. They are now trading at an all-time low while the short interest has jumped...
2023-11-02 10:00:00 ET Novavax (NASDAQ: NVAX) is facing some significant headwinds. Its financials aren't in great shape, and its future remains questionable. Investors have been dumping the stock in droves, and it is no longer near the highs it reached toward the start of the year....
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023 PR Newswire GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based...
2023-11-01 15:37:18 ET More on BioNTech, Moderna, etc. Pfizer Inc. (PFE) Q3 2023 Earnings Call Transcript Pfizer Inc. 2023 Q3 - Results - Earnings Call Presentation Moderna: Looking Beyond Covid, The Pipeline Is Promising Will Moderna follow Pfizer’s d...
2023-10-31 17:21:48 ET More on Novavax Moderna Vs. Novavax: Neither Offering Short-Term Value As Fall Vaccine Season Begins Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Novavax's COVID-19 Investment Thesis Is Old News Novavax wi...
Novavax's Updated COVID-19 Vaccine Now Approved in the EU PR Newswire Novavax's updated COVID-19 vaccine is the only updated protein-based non-mRNA COVID-19 vaccine available in the European Union for individuals aged 12 and older Novavax is working closely with EU m...
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU PR Newswire Pending a European Commission decision, Novavax's vaccine will be the only updated protein-based non-mRNA COVID-19 vaccine available in Europe for individuals a...
2023-10-31 07:19:25 ET More on Pfizer Pfizer: Ignore The Noise And Buy This Deep Value Seagen's Acquisition: EU Approval And Potential Upside Pfizer: Huge Upside Potential And 5%+ Yield Pfizer reports mixed Q3 earnings; reaffirms FY23 outlook GSK is s...
2023-10-27 15:00:00 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...
2023-10-27 09:11:19 ET Summary Moderna, the world leader in mRNA vaccines, has seen its revenues collapse due to waning Covid severity and global immunity. Its stock price is close to a three-year low. However, the company pipeline is rich and has new treatments (Merck-Moderna Key...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...